Lambert-Eaton Myasthenic Syndrome

📋Overview

The condition occurs when the immune system produces antibodies that target voltage-gated calcium channels at the neuromuscular junction, which reduces the release of the neurotransmitter acetylcholine. This disruption prevents muscles from contracting normally, leading to the clinical observation of weakness.

This syndrome is frequently associated with underlying malignancies, particularly small cell lung cancer, though it can also occur as a primary autoimmune disorder. It is characterized by a failure of the presynaptic nerve terminals to effectively communicate with muscle fibers.